These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27481908)

  • 41. Cardiovascular risk factors in women with and without rheumatoid arthritis.
    Solomon DH; Curhan GC; Rimm EB; Cannuscio CC; Karlson EW
    Arthritis Rheum; 2004 Nov; 50(11):3444-9. PubMed ID: 15529391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular disease risk profiles in inflammatory joint disease entities.
    Wibetoe G; Ikdahl E; Rollefstad S; Olsen IC; Bergsmark K; Kvien TK; Salberg A; Soldal DM; Bakland G; Lexberg Å; Fevang BT; Gulseth HC; Haugeberg G; Semb AG
    Arthritis Res Ther; 2017 Jul; 19(1):153. PubMed ID: 28673314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care.
    Weijers JM; Rongen-van Dartel SAA; Hoevenaars DMGMF; Rubens M; Hulscher MEJL; van Riel PLCM
    Ann Rheum Dis; 2018 Apr; 77(4):480-483. PubMed ID: 29167154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.
    Ajeganova S; de Faire U; Jogestrand T; Frostegård J; Hafström I
    J Rheumatol; 2012 Jun; 39(6):1146-54. PubMed ID: 22589258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.
    Chodara AM; Wattiaux A; Bartels CM
    Curr Rheumatol Rep; 2017 Apr; 19(4):16. PubMed ID: 28361332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
    Jacobsson LT; Turesson C; Gülfe A; Kapetanovic MC; Petersson IF; Saxne T; Geborek P
    J Rheumatol; 2005 Jul; 32(7):1213-8. PubMed ID: 15996054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis.
    van Breukelen-van der Stoep DF; Zijlmans J; van Zeben D; Klop B; van de Geijn GJ; van der Meulen N; Hazes M; Birnie E; Castro Cabezas M
    Scand J Rheumatol; 2015; 44(6):443-8. PubMed ID: 26169960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
    Kapetanovic MC; Lindqvist E; Simonsson M; Geborek P; Saxne T; Eberhardt K
    Scand J Rheumatol; 2010; 39(5):353-9. PubMed ID: 20615160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis.
    Wolfe F; Michaud K
    Arthritis Rheum; 2008 Sep; 58(9):2612-21. PubMed ID: 18759273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.
    Sattui SE; Rajan M; Lieber SB; Lui G; Sterling M; Curtis JR; Mandl LA; Navarro-Millán I
    Semin Arthritis Rheum; 2021 Feb; 51(1):292-298. PubMed ID: 33433365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
    Arts EE; Fransen J; Den Broeder AA; van Riel PLCM; Popa CD
    Ann Rheum Dis; 2017 Oct; 76(10):1693-1699. PubMed ID: 28606965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing process of care in rheumatoid arthritis at McGill University hospitals.
    Li LM; Tessier-Cloutier B; Wang Y; Bernatsky S; Vinet E; Ménard HA; Panopalis P; Hazel E; Stein M; Cohen M; Starr M; Pineau C; Veilleux MÈ; Colmegna I
    J Clin Rheumatol; 2013 Jun; 19(4):175-9. PubMed ID: 23669798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study.
    Nikiphorou E; de Lusignan S; Mallen CD; Khavandi K; Bedarida G; Buckley CD; Galloway J; Raza K
    Heart; 2020 Oct; 106(20):1566-1572. PubMed ID: 32209618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of cardiovascular risk in rheumatoid arthritis.
    Solomon DH; Goodson NJ; Katz JN; Weinblatt ME; Avorn J; Setoguchi S; Canning C; Schneeweiss S
    Ann Rheum Dis; 2006 Dec; 65(12):1608-12. PubMed ID: 16793844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perceived and actual risk of cardiovascular disease in patients with rheumatoid arthritis in Korea: A cross-sectional study.
    Boo S; Froelicher ES; Yun JH; Kim YW; Jung JY; Suh CH
    Medicine (Baltimore); 2016 Oct; 95(40):e5117. PubMed ID: 27749595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of cardiovascular disease in rheumatoid arthritis.
    Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
    Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disease activity in rheumatoid arthritis and the risk of cardiovascular events.
    Solomon DH; Reed GW; Kremer JM; Curtis JR; Farkouh ME; Harrold LR; Hochberg MC; Tsao P; Greenberg JD
    Arthritis Rheumatol; 2015 Jun; 67(6):1449-55. PubMed ID: 25776112
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.